Karo Healthcare AB, a healthcare company, develops and markets over-the-counter products and prescription drugs for pharmacies, digital distribution channels, and retail sector in Sweden, Norway, Denmark, Finland, France, Germany, Italy, the United Kingdom, rest of Europe, the United States, and internationally. It offers skin health products under the E45, Remescar, Locobase, Decubal, and indy beauty brand names; intimate health products under the Pevaryl, Multi Gyn, Asan, and Selexid brands; digestive products under the Scheriproct and Hemoproct brand names; and foot health products under the Pevaryl, Nailner, CCS, and wortie brands. The company also provides wellness products under the nutravita, Alpha Foods, Flux, Allévo, and Lactocare brand names; pain, cough, and cold products under the Paracet, Ibux, Mollipect, and Viruseptin brands; and specialty products under the Burinex, Centyl, Kaleorid, and Lithionit brand names. It sells its products in Europe and the Nordic region markets through direct sales organizations and a network of distributors, as well as online. Karo Healthcare AB was formerly known as Karo Pharma AB (publ). The company was incorporated in 1987 and is headquartered in Stockholm, Sweden. Karo Healthcare AB operates as a subsidiary of Karo Intressenter AB.